Safety and Immunogenicity of a Fourth Dose of Omicron BA.1–Adapted BNT162b2 COVID-19 Vaccines in Adults 18–55 Years Old
2026 · Clinical Infectious Diseases · 0 citations
https://doi.org/10.1093/cid/ciag026
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
0
Papers
0
Citations
David Fitz-Patrick is an academic researcher.
Click to start Chat